2008
DOI: 10.2967/jnumed.108.052050
|View full text |Cite
|
Sign up to set email alerts
|

Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
54
1

Year Published

2010
2010
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(59 citation statements)
references
References 33 publications
(60 reference statements)
4
54
1
Order By: Relevance
“…One study, Fuster et al [9], found that PET led to a change in the initial staging in 42% of patients. These advantages have been recently described in a study by Heusner et al [36] who has suggested that whole body PET/CT can provide a 'one stop' staging examination for patients with breast cancer. If used in this way then the emphasis when staging the axilla would be on a low false positive rate, which would limit the number of unnecessary axillary clearances.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…One study, Fuster et al [9], found that PET led to a change in the initial staging in 42% of patients. These advantages have been recently described in a study by Heusner et al [36] who has suggested that whole body PET/CT can provide a 'one stop' staging examination for patients with breast cancer. If used in this way then the emphasis when staging the axilla would be on a low false positive rate, which would limit the number of unnecessary axillary clearances.…”
Section: Discussionmentioning
confidence: 95%
“…Similarly, studies which contained patients with benign tumours were included, but the benign patient data was excluded from the analysis. We also excluded one potentially eligible study as the FP/TN results could not be extracted [36]. Twenty-five studies were found to satisfy these criteria.…”
Section: Methodsmentioning
confidence: 99%
“…However, most of these series mixed patients with stage II or IIIA carcinoma with others having inflammatory or locally advanced stages IIIB or IIIC breast cancer (2)(3)(4)(5)(6).…”
mentioning
confidence: 99%
“…As an example, MR breast imaging has a high sensitivity in the detection of breast lesions but a relatively low specificity [17]. In comparison, [ 18 F]FDG PET/CT imaging has gained a significant role in the detection and staging of breast cancer patients with a higher specificity than MR mammography [18,19]. Fusion of MR and PET data should, therefore, combine the high sensitivity of MR imaging for detection of breast lesions and the high specificity of PET for differentiating a benign from a malignant lesion [6].…”
Section: Pet/mr or Pet/ct?mentioning
confidence: 99%